Oxandrolone 10 - Androlex

Pioneering the era of safer anabolic therapy, Oxandrolone entered medical practice in 1962 through the work of G.D. Searle & Co. Known commercially as Anavar, it treated patients facing severe catabolic stress or delayed development. Its low risk of virilizing effects made it suitable even in sensitive populations. However, concerns about misuse in sport prompted its discontinuation in 1989. In 1995, Oxandrin brought the molecule back into circulation under orphan drug designation, with uses limited to severe medical conditions such as HIV-related muscle loss and Turner syndrome.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandrolone 10 by Androlex, consult with your doctor or healthcare professional.